PAVmed Inc. (PAVM) stock
PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.51−0.24 (-13.71%)
Close on Nov 17, 2026Market cap $12.07MP/E –Yield –
PAVmed gross margin
Gross margin is gross profit as a percentage of revenue.
PAVmed's gross margin for the twelve months ending Jun 30, 2026 was -220.5%. For fiscal 2025 it was -207.0%, against -61.6% the year before. The highest annual figure on record is -17.0% in fiscal 2021.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -207.0% | −145.4 |
| FY2024 | Dec 31, 2024 | -61.6% | +100.2 |
| FY2023 | Dec 31, 2023 | -161.8% | +696.8 |
| FY2022 | Dec 31, 2022 | -858.6% | −841.6 |
| FY2021 | Dec 31, 2021 | -17.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -269.7% | +313.6 |
| Q1 FY2026 | Mar 31, 2026 | -340.9% | +9.1 |
| Q4 FY2025 | Dec 31, 2025 | -63.5% | +316.5 |
| Q3 FY2025 | Sep 30, 2025 | -1000.0% | −961.3 |
| Q2 FY2025 | Jun 30, 2025 | -583.3% | −513.2 |
| Q1 FY2025 | Mar 31, 2025 | -350.0% | −277.3 |
| Q4 FY2024 | Dec 31, 2024 | -380.0% | −326.4 |
| Q3 FY2024 | Sep 30, 2024 | -38.7% | +86.3 |
| Q2 FY2024 | Jun 30, 2024 | -70.2% | +844.9 |
| Q1 FY2024 | Mar 31, 2024 | -72.7% | +129.1 |
| Q4 FY2023 | Dec 31, 2023 | -53.6% | +1291.1 |
| Q3 FY2023 | Sep 30, 2023 | -124.9% | +1914.6 |
| Q2 FY2023 | Jun 30, 2023 | -915.1% | −819.8 |
| Q1 FY2023 | Mar 31, 2023 | -201.8% | −154.8 |
| Q4 FY2022 | Dec 31, 2022 | -1344.6% | −1372.6 |
| Q3 FY2022 | Sep 30, 2022 | -2039.5% | – |
| Q1 FY2022 | Mar 31, 2022 | -95.2% | – |
| Q4 FY2021 | Dec 31, 2021 | -47.0% | – |
| Q3 FY2021 | Sep 30, 2021 | 28.0% | – |
See a number that looks wrong?